• Tables 2 and 3 provide more detail on the requirements for clinical systematic reviews for each HTA body. Table 4 provides detail on the requirements for economic reviews (including economic models, utilities, and cost and resource use) for those HTA bodies that provide guidance on these reviews (i.e., CADTH, NICE, HAS, NCPE, and SMC).
• NICE and G-BA requirements are the most prescriptive, whereas AWMSG and TLV have few stated SLR requirements.
• All agencies require a clinical SLR; AWMSG does not specify this outright but a clinical SLR is required to determine economic model inputs.
• Five agencies require both a clinical SLR and a critical appraisal of the included studies (PBAC, NICE, HAS, G-BA, and NCPE), although recommended appraisal tools vary.
• CADTH, NICE, and HAS require both an SLR and a critical appraisal of existing economic evaluations for the intervention of interest; PBAC requires an SLR of only economic evaluations and no critical appraisal.
• NICE, NCPE, SMC, and AWMSG require an SLR of utility data, but only NICE and SMC specify the need for an SLR of cost and resource use data.
CONCLUSIONS
• Although SLR requirements vary between HTA agencies, a clinical SLR is a key requirement for eight of the nine agencies investigated.
• Efficiencies can be gained by conducting SLRs designed to satisfy requirements of several HTA bodies.
• Clinical SLRs intended for use across several markets should be conducted in line with the most prescriptive guidance (i.e., G-BA and NICE). However, quality assessment guidance for clinical data varies between HTA bodies, with G-BA requiring the most detailed assessment.
• SLRs of economic models, utility data, and cost and resource use intended for use across several markets should be conducted to satisfy the prescriptive CADTH and NICE criteria. However, guidance for critical appraisal of economic models varies between HTA bodies requiring these (NICE, CADTH, and HAS).
• The checklist and summary tables should be updated as newer HTA guidance is issued.
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